It is a pharma private limited company based in Pune, Maharashtra, India, established in 2018.
2018 | Pune, Maharashtra, India | ActiveGypsopiea Pharmaceutical Private Limited, a active private limited company, was established on 23 October 2018 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52609PN2018PTC179741. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Employing 19 professional, Its leadership includes Imran Adam Shaikh (Director), Alok Kumar Pradhan (Director), Avinash Bhausaheb Kadam (Additional Director). Past directors included Avinash Bhausaheb Kadam, Sagar Gajanan Bhapkar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sr No 4/2/1/1 Lane No 04 Kakade Wasti, Pune, Maharashtra, 411048.
U52609PN2018PTC179741
179741
23 October 2018
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Gypsopiea Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Imran Adam Shaikh | Director | 23 Oct 2018 | Current |
| Alok Kumar Pradhan | Director | 23 Oct 2018 | Current |
| Avinash Bhausaheb Kadam | Additional Director | 26 Mar 2019 | Current |
| Sagar Gajanan Bhapkar | Additional Director | 26 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jan 2019 | Past |
| Pramod Abcsdd | Director | 07 Jan 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gypsopiea Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 93.06% increase. The company also saw a substantial improvement in profitability, with a 267.62% increase in profit. The company's net worth Soared by an impressive increase of 199.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Gypsopiea Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Gypsopiea Pharmaceutical has a workforce of 19 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gypsopiea Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gypsopiea Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gypsopiea Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Gypsopiea Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
Avinash Bhausaheb Kadam was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
The activity Sagar Gajanan Bhapkar was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2019 & has been associated with this company since 6 years 9 months . was completed.
Imran Adam Shaikh was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
Progress on Alok Kumar Pradhan was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 2 months . was documented.
The CIN of Gypsopiea Pharmaceutical Private Limited is U52609PN2018PTC179741.
Gypsopiea Pharmaceutical Private Limited is headquartered at Sr No 4/2/1/1 Lane No 04 Kakade Wasti, Pune, Maharashtra, 411048.
Gypsopiea Pharmaceutical Private Limited was incorporated on 23 October 2018.
The current directors of Gypsopiea Pharmaceutical Private Limited are
The primary industry of Gypsopiea Pharmaceutical Private Limited is Trade.
Gypsopiea Pharmaceutical Private Limited is unlisted.
The authorized capital of Gypsopiea Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX